Continuous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment May Not Hinder the Survival of Patients with Primary Lung Adenocarcinoma despite Indolent New Lesions

立忠 邱; 澤宏 黃; Kuo-Chin Kao; 忠恕 李; Chung-Chi Huang; 志騰 余; Ning-Hung Chen; Cheng-Ta Yang; Ying-Huang Tsai; 劍英 劉

Continuous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment May Not Hinder the Survival of Patients with Primary Lung Adenocarcinoma despite Indolent New Lesions

邱立忠
, 黃澤宏
, Kuo-Chin Kao
, 李忠恕
, Chung-Chi Huang
, 余志騰
, Ning-Hung Chen
, Cheng-Ta Yang
, Ying-Huang Tsai
, 劉劍英

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Pages (from-to)	73-88
Journal	胸腔醫學
Volume	28
Issue number	2
State	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{93621e0f54404922a8f79d1cda543328,

title = "Continuous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment May Not Hinder the Survival of Patients with Primary Lung Adenocarcinoma despite Indolent New Lesions",

keywords = "Epidermal growth factor receptor tyrosine kinase inhibitors, New lesions, Overall survival, Progression-free survival, Progressive disease, 整體存活期, 新病灶, 無惡化存活期, 病情惡化",

author = "立忠邱 and 澤宏黃 and Kuo-Chin Kao and 忠恕李 and Chung-Chi Huang and 志騰余 and Ning-Hung Chen and Cheng-Ta Yang and Ying-Huang Tsai and 劍英劉",

year = "2013",

language = "American English",

volume = "28",

pages = "73--88",

journal = "胸腔醫學",

issn = "1023-9855",

number = "2",

}

TY - JOUR

T1 - Continuous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment May Not Hinder the Survival of Patients with Primary Lung Adenocarcinoma despite Indolent New Lesions

AU - 邱, 立忠

AU - 黃, 澤宏

AU - Kao, Kuo-Chin

AU - 李, 忠恕

AU - Huang, Chung-Chi

AU - 余, 志騰

AU - Chen, Ning-Hung

AU - Yang, Cheng-Ta

AU - Tsai, Ying-Huang

AU - 劉, 劍英

PY - 2013

Y1 - 2013

KW - Epidermal growth factor receptor tyrosine kinase inhibitors

KW - New lesions

KW - Overall survival

KW - Progression-free survival

KW - Progressive disease

KW - 整體存活期

KW - 新病灶

KW - 無惡化存活期

KW - 病情惡化

M3 - Journal Article

SN - 1023-9855

VL - 28

SP - 73

EP - 88

JO - 胸腔醫學

JF - 胸腔醫學

IS - 2

ER -